Purpose: Ankaferd Blood Stopper (ABS) is an herbal extract attained from 5 different plants. It has the therapeutic potential to be used for the management of external hemorrhage and controlling gastrointestinal bleedings. To date, the safety of ABS for intraperitoneal usage is not clear. In this study, we investigated the effectiveness and safety of using intraperitoneal ABS in an experimental peritoneal adhesion model.
Methods: Twenty-four male Wistar Albino rats were used in the study. The rats were randomly divided into 3 groups: saline, ABS, and control. On the 10th day, all rats were euthanized. The adhesions were evaluated by Nair's macroscopic adhesion classification, and pathologically evaluated with Zühlke's microscopic adhesion classification.
Results: macroscopic and microscopic comparison between the ABS and saline groups did not show any differences but both the ABS and saline groups were superior when compared to the control group.
Conclusion: ABS was found equally effective with saline on the abdominal adhesions and to no effect on postoperative adhesion formation.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4826984 | PMC |
| http://dx.doi.org/10.4174/astr.2016.90.4.213 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The amelioration effects of ankaferd blood stopper, platelet gel, and Momordica charantia on peripheral nerve injury in the rats: a stereological and ultrastructural study.
Histochem Cell Biol
November 2024
Department of Histology and Embryology, Faculty of Medicine, Ondokuz Mayıs University, Samsun, Türkiye.
Peripheral nerve injuries are commonly encountered in clinical practice. Peripheral nerve injuries most commonly result in serious problems affecting quality of life. The present study is designed to research the possible neuroprotective effects of Ankaferd blood stopper (ABS), platelet-rich plasma (PRP), and Momordica charantia (MC) on regeneration using unbiased stereological techniques.
View Article and Find Full Text PDFAnkaferd blood stopper: A novel additional strategy for less experienced gastroenterologists in gastrointestinal bleeding treatment.
Medicine (Baltimore)
May 2024
Department of Gastroenterology, Ondokuz Mayis University, School of Medicine, Samsun, Turkey.
The Ankaferd Blood Stopper (ABS) proves effective in managing various bleedings, particularly in surgical and dental procedures. This study assesses ABS efficacy endoscopically by less-experienced endoscopists for non-variceal upper gastrointestinal bleeding (NVUGB). Between 2016 and 2021, our hospital's Gastroenterology Department Endoscopy Unit conducted a retrospective data analysis of 653 patients who underwent endoscopy for NVUGB.
View Article and Find Full Text PDFFunctional and structural neurodegenerative activities of Ankaferd BloodStopper in a mouse sciatic nerve model.
Exp Ther Med
September 2024
Department of Physiology, School of Medicine, Aksaray University, Aksaray 68100, Turkey.
Traumatic and postoperative hemorrhages are life-threatening complications. Ankaferd BloodStopper (ABS) is a potent topical hemostatic agent to stop bleeding. However, ABS is associated with nerve toxicity.
View Article and Find Full Text PDFDetermination of the Effects of Ankaferd Wound Dressing on the Wound Healing Process in Rats.
Turk J Pharm Sci
May 2024
Necmettin Erbakan University Meram Vocational School, Department of Property Protection and Security, Konya, Türkiye.
Objectives: The effects of a composite nanofiber wound dressing material consisting of a polyvinylidene alcohol and polyvinylidene pyrrolidone polymer mixture with a hemostatic agent doped with Ankaferd Blood Stopper (ABS) on the healing of experimentally induced dermal wounds in rats were examined.
Materials And Methods: Rats were divided into 4 groups (n= 6). Histological material was examined on tissues taken from the wound site, whereas total antioxidant status (TAS), total oxidant status (TOS), and oxidative stress index (OSI) analyses were performed on blood samples taken from the cardia.
Management of iatrogenic airway bleeding with flexible bronchoscopy: Evidence or experience-based?
Tuberk Toraks
December 2023
Department of Chest Diseases, Hacettepe University Faculty of Medicine, Ankara, Türkiye.
Article Synopsis
- Iatrogenic bleeding during bronchoscopy can cause serious complications like early termination, inadequate samples, reduced diagnostic accuracy, and even death.
- Management of this bleeding during flexible fiberoptic bronchoscopy is limited to using liquids since methods like cautery can't be applied.
- Current treatments involve vasoconstriction and enhancing coagulation, but there's a lack of robust studies on the effectiveness and safety of these agents, leading to uncertainty in best practices.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!